VanEck Biotech ETF (BBH:NASDAQ) closed at $246.57 on October 23, 2026, down 0.38% on the day. The stock trades 1.9% below its 52-week high of $251.45 and 39.9% above its 52-week low of $176.30. VanEck Biotech ETF is part of the Miscellaneous sector.
In 252 trading sessions since October 23, 2025, BBH closed higher on 125 days (50%). Its best day was August 19, 2026 (+8.70%) and its worst was September 8, 2026 (-3.64%). It never moved 10% or more in a single session.
The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVISä US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Find more stocks like BBH with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.